January 05, 2026 a 08:00 am
BDX: Fundamental Ratio Analysis - Becton, Dickinson and Company
Becton, Dickinson and Company exhibits a robust portfolio in the medical supplies and devices sector. This helps it maintain a stable market position. However, the company's current valuation reflects certain challenges such as debt levels that should be watched attentively.
Fundamental Rating
Becton, Dickinson and Company's fundamental scores indicate a moderate performance. While the Discounted Cash Flow score is strong, the company's debt management could be improved.
| Category | Score | Visualization |
|---|---|---|
| Overall Score | 3 | |
| Discounted Cash Flow | 5 | |
| Return on Equity | 3 | |
| Return on Assets | 3 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 3 |
Historical Rating
While the fundamentals show consistency, recent ratings highlight the need for vigilance in financial management.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-01-02 | 3 | 5 | 3 | 3 | 1 | 2 | 3 |
| N/A | 0 | 5 | 3 | 3 | 1 | 2 | 3 |
Analyst Price Targets
The analyst price targets indicate a consensus that the stock is currently well-accounted price-wise.
| High | Low | Median | Consensus |
|---|---|---|---|
| $210 | $210 | $210 | $210 |
Analyst Sentiments
Analysts' sentiment remains positive, with a level-headed distribution across buy, hold, and sell.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 16 | |
| Hold | 16 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
Becton, Dickinson and Company has shown dependability in its fundamental analysis, though caution is advised regarding its debt levels. Analysts see the company as fairly valued, with potential for stability in its performance. The positive sentiment among analysts reflects expectations for future growth, yet investors should consider potential risks related to financial leverage. Overall, it's a strong entity with room for improvements in financial metrics.